Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Crawl-delay: |
Title | Targeting the - Stelexis |
Description | Toggle Navigation Search: About Us Our Approach Our Programs Team Investors News Careers Contact Targeting the Tumor’s Origin About Us Stelexis Therapeuti |
Keywords | N/A |
WebSite | stelexis.com |
Host IP | 199.250.194.142 |
Location | United States |
Site | Rank |
US$352,853
Last updated: 2023-05-01 00:41:54
stelexis.com has Semrush global rank of 29,996,405. stelexis.com has an estimated worth of US$ 352,853, based on its estimated Ads revenue. stelexis.com receives approximately 40,714 unique visitors each day. Its web server is located in United States, with IP address 199.250.194.142. According to SiteAdvisor, stelexis.com is safe to visit. |
Purchase/Sale Value | US$352,853 |
Daily Ads Revenue | US$326 |
Monthly Ads Revenue | US$9,772 |
Yearly Ads Revenue | US$117,256 |
Daily Unique Visitors | 2,715 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
stelexis.com. | A | 299 | IP: 199.250.194.142 |
stelexis.com. | NS | 86400 | NS Record: ns13.dnsmadeeasy.com. |
stelexis.com. | NS | 86400 | NS Record: ns14.dnsmadeeasy.com. |
stelexis.com. | NS | 86400 | NS Record: ns15.dnsmadeeasy.com. |
stelexis.com. | NS | 86400 | NS Record: ns10.dnsmadeeasy.com. |
stelexis.com. | NS | 86400 | NS Record: ns11.dnsmadeeasy.com. |
stelexis.com. | NS | 86400 | NS Record: ns12.dnsmadeeasy.com. |
stelexis.com. | MX | 600 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
stelexis.com. | MX | 600 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
stelexis.com. | TXT | 300 | TXT Record: S3VSF10T8O6MU8HPMLQ1H3SKVF |
Toggle Navigation Search: About Us Our Approach Our Programs Team Investors News Careers Contact Targeting the Tumor’s Origin About Us Stelexis Therapeutics is committed to transforming cancer treatment through the discovery of novel targets aimed at the tumor’s origin. Pre-cancer and cancer stem cells (cancerous stem cells) are a primary cause of cancer progression and relapse, and they’re typically not eliminated by current treatment approaches. Previously, identifying targets on cancerous stem cells was almost impossible due to difficulties isolating, propagating and maintaining clinically relevant stem cells for research. Aided by seminal discoveries at leading academic institutions, the Company has developed a proprietary platform, called TumorOrigin™, which enables unprecedented study of these cells for drug discovery. Our Approach The TumorOrigin™ platform is designed to discover novel, druggable targets on cancerous stem cells. Utilizing large banks of patient-derived samples, |
HTTP/1.1 406 Not Acceptable Server: nginx/1.21.3 Date: Sat, 23 Oct 2021 16:58:43 GMT Content-Type: text/html; charset=iso-8859-1 Content-Length: 300 Connection: keep-alive |
Domain Name: STELEXIS.COM Registry Domain ID: 2116369085_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-10-05T17:32:20Z Creation Date: 2017-04-21T13:01:03Z Registry Expiry Date: 2029-04-21T13:01:03Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS10.DNSMADEEASY.COM Name Server: NS11.DNSMADEEASY.COM Name Server: NS12.DNSMADEEASY.COM Name Server: NS13.DNSMADEEASY.COM Name Server: NS14.DNSMADEEASY.COM Name Server: NS15.DNSMADEEASY.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T03:00:29Z <<< |